July 4, 2022

EXPO Magazine

Complete News World

China approves Coronavac use for 3-year-olds, Sinovak | Vaccine

A China Coronavac is approved for children and adolescents between the ages of 3 and 17, the director of the Sinovak laboratory that developed the vaccine announced Friday (4). With recognition, the country changes The world’s first to approve the Govt vaccine for children.

It is not yet known when children will be vaccinated.

“Sinovak conducted a clinical study on small populations [de idade]It started earlier this year after the completion of the first and second phase of clinical trials, ”Sinovak director Yin Widong told Chinese state television CCTV, according to the South China Morning Post.

“After the vaccination, the group showed hundreds of cases [de 3 a 17 anos] It’s as safe as an 18 – year – old group, “said Yin Weidong, a spokesman for the British newspaper The Lancet.

According to the “Our World Data” survey affiliated with the University of Oxford, As of June 7, China had already delivered 794.13 million doses of the vaccine. There is no data on how many drugs are available for first or second use or how many people are fully vaccinated.

In addition to Coronavac, China also uses vaccines from Coronavac. Synoform (Editions of Wuhan and Beijing) and Consino. CanSino s are given in a single dose; Coronavac and Sinoform have two sizes.

A Coronavac And vaccination Synoform Made in Beijing already has World Health Organization emergency utilization approval (WHO) In adults.

Pfizer extends testing to children under 12 years of age

This Tuesday (8), Pfizer announced the announcement Increase the number of children under 12 years of age In testing their vaccine in Europe and the United States.

The new study will cover up to 4,500 children and adolescents in more than 90 medical centers in the United States, Finland, Poland and Spain, the company said.

Pfizer will test two doses of 10µg (micrograms) in children aged 5 to 11 years, and 3µg in children aged 6 months to 5 years.

In the previous phase, the defense, tolerance and immune response developed by 144 infants and children aged 6 months to 11 years was tested at one point I was studying. The vaccination schedule was two doses, with 3 different doses of the vaccine: 10, 20 or 30µg for each age group.

What vaccine is this?  Oxford AstraZeneca

What vaccine is this? Oxford AstraZeneca

The Coronavac and Pfizer vaccines are used in Brazil. Third Oxford / AstraZeneca vaccine. The Johnson / Johnson vaccine is also approved for use in the country, but the first dose has not yet arrived.

Watch vaccination videos in Brazil: